Customer Q&A: Novartis

Novartis has a rich history of investing in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs. As the industry faces acute disruption, the company’s prescription for ongoing success hinges on APIs and microservices. Pascal Bouquet, Global Head of Architecture for Drug Development, answers a few questions about how digital transformation is moving Novartis forward.  

Previous Asset
OneHealthPort delivers secure gateway for API-driven communications
OneHealthPort delivers secure gateway for API-driven communications

OneHealthPort gives healthcare providers seamless data-sharing in the cloud

Next Asset
The right infrastructure for the right time in healthcare - a Frost & Sullivan White Paper
The right infrastructure for the right time in healthcare - a Frost & Sullivan White Paper

A look at health plans, providers and hybrid integration platforms to best enable the digital era